Treatment of Metabolic Syndrome patients in Thailand region using Shu Gan Tiao Shen needling method

Phase 1

Recruiting

• Conditions: Metabolic syndrome patients; Metabolic syndrome Acupuncture Shu Gan Tiao Shen

• Registration Number: TCTR20230712008
• Lead Sponsor: Huayploo hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-07-12
• Last Update Posted: 19 August 2024
• Study Completion: 2025-03-22

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

1. Symptom of metabolic syndrome correspond to IDF
2. Age between 20 to 65 years, regardless of gender and weight.
3. Absence of gastrointestinal disease such as diarrhea, constipation, etc. within 4 weeks.
4. Consent to participate in the research project. and sign a letter of consent to participate in the research project

Exclusion Criteria

1. Are at risk of coming into contact with a COVID19 infected person or cluster or have a history of traveling to the area with an epidemic.
2. Have been diagnosed with depression or severe mental illness or have a tendency to committed suicide.
3. Patients with heart disease, stroke, lung, liver, kidney, cancer patients, infectious disease patients.
4. People who take medication to treat metabolic syndrome symptoms within 6 weeks or use Antibiotics, probiotics, prebiotics or internal gastrointestinal motility drugs 4 weeks
5. Those who are unable to cooperate in the investigation and treatment.
6. Women who are pregnant or breastfeeding.
7. People who have a fever of 37.5 degrees Celsius or more with cough, runny nose, sore throat, shortness of breath.
8. People who use drugs that act on the nervous system. and circulatory system.
9. Have been treated with acupuncture before

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IDF Metabolic syndrome Before and Immediately after end of the intervention BMI BP FPG TG HDL Waist circumference

Secondary Outcome Measures

Name	Time	Method
Gut microbiome Before and Immediately after end of the intervention Stool sample culture,SF-36 Before and Immediately after end of the intervention Survey,PHQ-9 Before and Immediately after end of the intervention Survey,ST-5 Before and Immediately after end of the intervention Survey